ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements

Maria M. Crespo, Tamara Claridge, Robyn T. Domsic, Matthew Hartwig, Jasleen Kukreja, Kathleen Stratton, Kevin M. Chan, Maria Molina, Patricia Ging, Adam Cochrane, Konrad Hoetzenecker, Usman Ahmad, Siddhartha Kapnadak, Irina Timofte, Geert Verleden, Dennis Lyu, Sana Quddus, Nicole Davis, Mary Porteous, Jorge MalleaMichael Perch, Olivier Distler, Kristin Highland, Jesper Magnusson, Robin Vos, Allan R. Glanville

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Patients with connective tissues disease (CTD) are often on immunomodulatory agents before lung transplantation (LTx). Till now, there's no consensus on the safety of using these agents perioperative and post-transplant. The International Society for Heart and Lung Transplantation-supported consensus document on LTx in patients with CTD addresses the risk and contraindications of perioperative and post-transplant management of the biologic disease-modifying antirheumatic drugs (bDMARD), kinase inhibitor DMARD, and biologic agents used for LTx candidates with underlying CTD, and the recommendations and management of non-gastrointestinal extrapulmonary manifestations, and esophageal disorders by medical and surgical approaches for CTD transplant recipients.

Original languageEnglish (US)
Pages (from-to)1279-1300
Number of pages22
JournalJournal of Heart and Lung Transplantation
Volume40
Issue number11
DOIs
StatePublished - Nov 2021
Externally publishedYes

Keywords

  • biologic disease-modifying anti rheumatic drugs
  • connective tissue diseases
  • consensus statement
  • esophageal disorders post-transplant medical and surgical management
  • feedings
  • lung transplantation

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint

Dive into the research topics of 'ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements'. Together they form a unique fingerprint.

Cite this